We use the Taqpath RT-PCR assay on SARS-CoV-2 positive samples to detect the so called S gene dropout (the S gene PCR target is not amplified, while the two other targets are detected). This constellation currently indicates the presence of the Omicron variant with a high probability. Whole genome sequencing performed on SARS-CoV-2 positive samples with a CT value <32 allows for definitive confirmation. Samples included in this graph come exclusively from people screened at our outpatient testing centers.
- Demandes d'analyses
- Centres nationaux de référence
- Centre des maladies virales émergentes
New Coronavirus « SARS-CoV-2 » (for patient, tests SARS-CoV-2/COVID-19 must be requested through a doctor)
Since January 16, 2020, the Virology Laboratory is able to perform molecular diagnosis (PCR) in case of suspicion of "SARS-CoV-2", the new emerging coronavirus in China. For more information, click here
Hotline (answering machine) for the SARS-CoV-2: Tel. 079 55 35 732 (8am-8pm, 7/7)
Analyses carried out 7/7d. Due to the overload of the virology laboratory, we thank you not to contact us to obtain a result, all the results are distributed as quickly as possible on the available addresses. Thank you for your understanding.
The Virology Laboratory performs diagnostic tests for the entire Geneva University Hospitals These activities include viral culture, molecular tests and infectious serology. More than 120,000 analyses are carried out each year.
The laboratory is divided into two parts that are separated geographically (LV1 and LV2), the two are located at the main site of the Geneva University Hospitals.